H.R. 254 · 117th Congress · House

Neuromyelitis Optica Spectrum Disorder Consortium Act

Active· Referred to the Subcommittee on Health.
Introduced
Jan 11, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Neuromyelitis Optica Spectrum Disorder Consortium Act

This bill requires the National Institutes of Health to establish a national consortium to coordinate and support research on neuromyelitis optica spectrum disorder, including by awarding grants. This is a neurological disease that can cause blindness, paralysis, and premature death.

Action Timeline

4
  1. FEB 02, 2021Committee

    Referred to the Subcommittee on Health.

  2. JAN 11, 2021IntroReferral

    Introduced in House

  3. JAN 11, 2021IntroReferral

    Introduced in House

  4. JAN 11, 2021IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Feb 3, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Jan 11, 2021

Active